Social Wire
Uploaded
11-04-2026
TCT 2026: EARLY TAVR: Cost-Effectiveness of TAVR
TCT 2026: EARLY TAVR: Cost-Effectiveness of TAVR TCT 2026 - Dr Neel Butala (University of Colorado School of Medicine, Au ...
Tweeted
11-04-2026
Radcliffe Cardiology
@radcliffeCARDIO The #AHA2026 late-breaking results are only the beginning. At #ScientificSessions26, Dr @hvanspall returns to host the Late-Breaking Discussions: 🩺 OPTIMAL → How low should BP go? 🧬 Lp(a)HORIZON → What can the full data teach us about Lp(a) lowering? ❤️ RACE-C/t.co/bWo1raIK41
Radcliffe Cardiology
@radcliffeCARDIO The #AHA2026 late-breaking results are only the beginning. At #ScientificSessions26, Dr @hvanspall returns to host the Late-Breaking Discussions: 🩺 OPTIMAL → How low should BP go? 🧬 Lp(a)HORIZON → What can the full data teach us about Lp(a) lowering? ❤️ RACE-C/t.co/bWo1raIK41
Tweeted
11-04-2026
Radcliffe Cardiology
@radcliffeCARDIO 🚨 New #CardioOnc Webinar | 'Journal Club: PRADA II' this Thursday. ⏰ 14:00 GMT | 09:00 EST Don’t miss out on this discussion with Dr Joe Carver, Dr Daniel Lenihan, Dr Jose Álvarez-Cardona and Dr Daniel Hwang. Registow.ly/lHXS5103JtA/sFI2aOQ55w This webinar is/wlTCKGLIRz
Radcliffe Cardiology
@radcliffeCARDIO 🚨 New #CardioOnc Webinar | 'Journal Club: PRADA II' this Thursday. ⏰ 14:00 GMT | 09:00 EST Don’t miss out on this discussion with Dr Joe Carver, Dr Daniel Lenihan, Dr Jose Álvarez-Cardona and Dr Daniel Hwang. Registow.ly/lHXS5103JtA/sFI2aOQ55w This webinar is/wlTCKGLIRz
Uploaded
11-04-2026
P4 at TCT 2026: Ajay Kirtane on Why PCI Operators Need to Know CT #interventionalcardiology
P4 at TCT 2026: Ajay Kirtane on Why PCI Operators Need to Know CT #interventionalcardiology Visit Radcliffe Cardiology: h ...
Tweeted
11-04-2026
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #ECRJournal Article: "Antiplatelet Strategies After PCI: Risk–Benefit Network Meta-Analysis" 📚 Just Published! 🔓Access it here 👉 https://t.co/suC58m7C8j #MedEd #CardioEd #Aow.ly/HJJ7106HPx8.co/suC58m7C8j #MedEd #CardioEd #An.co/iYrXOzzVA3
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #ECRJournal Article: "Antiplatelet Strategies After PCI: Risk–Benefit Network Meta-Analysis" 📚 Just Published! 🔓Access it here 👉 https://t.co/suC58m7C8j #MedEd #CardioEd #Aow.ly/HJJ7106HPx8.co/suC58m7C8j #MedEd #CardioEd #An.co/iYrXOzzVA3
Tweeted
11-03-2026
Radcliffe Cardiology
@radcliffeCARDIO ⚖️ Obesity is a key driver of cardiovascular-kidney-metabolic disease, but effective treatment options have never been greater. 📺 @WomenAs1 #CLIMB2026 presents Treatment of Obesity: Lifestyle, Medications and Bariatric Surgery with Dr Alison L Bailey. 🏃 Lifestyle htt 📺 @WomenAs1 #CLIMB2026 presents Treatment of Obesity: Lifestyle, Medications and Bariatric Surgery with Dr Alison L Bailey. 🏃 mNadXjNWRN
Radcliffe Cardiology
@radcliffeCARDIO ⚖️ Obesity is a key driver of cardiovascular-kidney-metabolic disease, but effective treatment options have never been greater. 📺 @WomenAs1 #CLIMB2026 presents Treatment of Obesity: Lifestyle, Medications and Bariatric Surgery with Dr Alison L Bailey. 🏃 Lifestyle htt 📺 @WomenAs1 #CLIMB2026 presents Treatment of Obesity: Lifestyle, Medications and Bariatric Surgery with Dr Alison L Bailey. 🏃 mNadXjNWRN
Uploaded
11-03-2026
TCT 26: 4 Trials That Will Change My Practice with Dr Ajay Kirtane
TCT 26: 4 Trials That Will Change My Practice with Dr Ajay Kirtane TCT 2026 - Which trials presented in San Diego could h ...
Tweeted
11-03-2026
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #CFRJournal Article: "Foreword: Sleep-disordered Breathing in Heart Failure" 📚 Just Published! 🔓Access it here 👉 https://t.co/TSuSPXpT9L @hfa_president #HeartFailure #CardioTwTSuSPXpT9L @hfa_president #HeartFailure #Cardiow.ly/6xSo106HKk7o/TSuSPXpT9L @hfa_president #HeartFailure #CardioTwio/A49BelZAcW
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #CFRJournal Article: "Foreword: Sleep-disordered Breathing in Heart Failure" 📚 Just Published! 🔓Access it here 👉 https://t.co/TSuSPXpT9L @hfa_president #HeartFailure #CardioTwTSuSPXpT9L @hfa_president #HeartFailure #Cardiow.ly/6xSo106HKk7o/TSuSPXpT9L @hfa_president #HeartFailure #CardioTwio/A49BelZAcW
Uploaded
11-03-2026
TCT 2026: The Global Burden of Degenerative Mitral Valve Disease
TCT 2026: The Global Burden of Degenerative Mitral Valve Disease Have advances in mitral intervention outpaced our abilit ...
Uploaded
11-03-2026
TCT 2026: PROGRESS: Should We Intervene Earlier in Moderate Aortic Stenosis?
TCT 2026: PROGRESS: Should We Intervene Earlier in Moderate Aortic Stenosis? TCT 2026 - In this expert discussion, Prof P ...
Uploaded
11-03-2026
PROGRESS Trial: Is It Time to Rethink Moderate Aortic Stenosis? #interventionalcardiology #tct2026
PROGRESS Trial: Is It Time to Rethink Moderate Aortic Stenosis? #interventionalcardiology #tct2026 Visit Radcliffe Cardio ...
Uploaded
11-02-2026
TCT 2026: Where Do Drug-Coated Balloons Fit in Modern PCI?
TCT 2026: Where Do Drug-Coated Balloons Fit in Modern PCI? Where do drug-coated balloons really fit in contemporary PCI, ...
Uploaded
11-02-2026
Is PCI Ready to Leave Nothing Behind? | TRANSFORM II #news #tct2026 #interventionalcardiology
Is PCI Ready to Leave Nothing Behind? | TRANSFORM II #news #tct2026 #interventionalcardiology Visit Radcliffe Cardiology: ...
Uploaded
11-02-2026
CT vs IVUS for PCI: Is P4 a Game-Changer? | #tct2026 #interventionalcardiology
CT vs IVUS for PCI: Is P4 a Game-Changer? | #tct2026 #interventionalcardiology Visit Radcliffe Cardiology: https://www.ra ...
Tweeted
11-02-2026
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #USCJournal Article: "ANOCA: Diagnostic Evaluation and Endotype-guided Management" 📚 Just Published! 🔓Access it here 👉 https://t.co/9Gh83PKIBU @CardioNerds #CVImaging #Med9Gh83PKIBU @CardioNerds #CVImaging #Meow.ly/l6Kn106HHjQo/9Gh83PKIBU @CardioNerds #CVImaging #MedEo/TP01oazeu0
Radcliffe Cardiology
@radcliffeCARDIO 📚 New #USCJournal Article: "ANOCA: Diagnostic Evaluation and Endotype-guided Management" 📚 Just Published! 🔓Access it here 👉 https://t.co/9Gh83PKIBU @CardioNerds #CVImaging #Med9Gh83PKIBU @CardioNerds #CVImaging #Meow.ly/l6Kn106HHjQo/9Gh83PKIBU @CardioNerds #CVImaging #MedEo/TP01oazeu0
Tweeted
11-02-2026
Radcliffe Cardiology
@radcliffeCARDIO 🫀 TEER or TTVR when both are technically possible? At #TCT2026, @drnvanmieghem and Dr Azeem Latib examine: ▪ Patient selection ▪ Residual TR ▪ RV function ▪ Quality of life vs harder outcomes ▪ Repair vs replacement, head-to-head? Watch discco/HGFAVnXbFu
Radcliffe Cardiology
@radcliffeCARDIO 🫀 TEER or TTVR when both are technically possible? At #TCT2026, @drnvanmieghem and Dr Azeem Latib examine: ▪ Patient selection ▪ Residual TR ▪ RV function ▪ Quality of life vs harder outcomes ▪ Repair vs replacement, head-to-head? Watch discco/HGFAVnXbFu
Tweeted
11-02-2026
Radcliffe Cardiology
@radcliffeCARDIO TRANSFORM II at #TCT2026 1,842 patients | 53 sites 📊 TLF: 2.1% SCB vs 2.4% EES ✓ Non-inferiority met 🔹 Bailout stenting: 7.6% Bernardo Cortese: “Only after five years will we know what is best in this lesion setting.” What do these data add to the de novo DCB o/JDdwFhoM1s
Radcliffe Cardiology
@radcliffeCARDIO TRANSFORM II at #TCT2026 1,842 patients | 53 sites 📊 TLF: 2.1% SCB vs 2.4% EES ✓ Non-inferiority met 🔹 Bailout stenting: 7.6% Bernardo Cortese: “Only after five years will we know what is best in this lesion setting.” What do these data add to the de novo DCB o/JDdwFhoM1s
Tweeted
11-01-2026
Radcliffe Cardiology
@radcliffeCARDIO P4 at #TCT2026: Can CT guide PCI? 1,100 patients, CCTA- vs IVUS-guided PCI: • 1-year TVF: 4.1% vs 4.6% • Non-inferiority achieved • 17 min shorter procedural time • 20 mL less contrast Dr Carlos Collet in conversation with @drnvanmieghem “Before you put your fo2vtaI1NaK1
Radcliffe Cardiology
@radcliffeCARDIO P4 at #TCT2026: Can CT guide PCI? 1,100 patients, CCTA- vs IVUS-guided PCI: • 1-year TVF: 4.1% vs 4.6% • Non-inferiority achieved • 17 min shorter procedural time • 20 mL less contrast Dr Carlos Collet in conversation with @drnvanmieghem “Before you put your fo2vtaI1NaK1
Uploaded
11-01-2026
What's the Right Heparin Dose for PCI? | HD-PCI
What's the Right Heparin Dose for PCI? | HD-PCI Does more heparin improve outcomes during elective PCI? The HD-PCI trial ...
Tweeted
11-01-2026
Radcliffe Cardiology
@radcliffeCARDIO Should treatment goals in severe hypertriglyceridaemia extend beyond lowering triglycerides? Ahead of AHA 2026, review the latest evidence from the SHASTA-3 and SHASTA-4 studies and hear expert perspectives on apoC-III inhibition and pancreatitis prevention from Dr Robert
Radcliffe Cardiology
@radcliffeCARDIO Should treatment goals in severe hypertriglyceridaemia extend beyond lowering triglycerides? Ahead of AHA 2026, review the latest evidence from the SHASTA-3 and SHASTA-4 studies and hear expert perspectives on apoC-III inhibition and pancreatitis prevention from Dr Robert
